Literature DB >> 16452680

Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex.

LeeAnn H Miner1, Hank P Jedema, Forrest W Moore, Randy D Blakely, Anthony A Grace, Susan R Sesack.   

Abstract

Norepinephrine (NE) potently modulates the cognitive and affective functions of the prefrontal cortex (PFC). Deficits in NE transmission are implicated in psychiatric disorders, and antidepressant drugs that block the NE transporter (NET) effectively treat these conditions. Our initial ultrastructural studies of the rat PFC revealed that most NE axons (85-90%) express NET primarily within the cytoplasm and lack detectable levels of the synthetic enzyme tyrosine hydroxylase (TH). In contrast, the remaining 10-15% of PFC NE axons exhibit predominantly plasmalemmal NET and evident TH immunoreactivity. These unusual characteristics suggest that most PFC NE axons have an unrecognized, latent capacity to enhance the synthesis and recovery of transmitter. In the present study, we used dual-labeling immunocytochemistry and electron microscopy to examine whether chronic cold stress, a paradigm that persistently increases NE activity, would trigger cellular changes consistent with this hypothesis. After chronic stress, neither the number of profiles exhibiting NET labeling nor their size was changed. However, the proportion of plasmalemmal NET nearly doubled from 29% in control animals to 51% in stressed rats. Moreover, the expression of detectable TH in NET-labeled axons increased from only 13% of profiles in control rats to 32% of profiles in stressed animals. Despite the consistency of these findings, the magnitude of the changes varied across individual rats. These data represent the first demonstration of activity-dependent trafficking of NET and expression of TH under physiological conditions and have important implications for understanding the pathophysiology and treatment of stress-related affective disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452680      PMCID: PMC6675488          DOI: 10.1523/JNEUROSCI.4450-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  Role of locus coeruleus in attention and behavioral flexibility.

Authors:  G Aston-Jones; J Rajkowski; J Cohen
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

2.  Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.

Authors:  S Schroeter; S Apparsundaram; R G Wiley; L H Miner; S R Sesack; R D Blakely
Journal:  J Comp Neurol       Date:  2000-05-01       Impact factor: 3.215

Review 3.  Biogenic amine transporters: regulation in flux.

Authors:  R D Blakely; A L Bauman
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

4.  Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals.

Authors:  L H Miner; S Schroeter; R D Blakely; S R Sesack
Journal:  J Comp Neurol       Date:  2000-11-13       Impact factor: 3.215

5.  Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats.

Authors:  L A Rosario; E D Abercrombie
Journal:  Brain Res Bull       Date:  1999-04       Impact factor: 4.077

6.  Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols.

Authors:  H P Jedema; A F Sved; M J Zigmond; J M Finlay
Journal:  Brain Res       Date:  1999-06-05       Impact factor: 3.252

Review 7.  Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder.

Authors:  S M Southwick; J D Bremner; A Rasmusson; C A Morgan; A Arnsten; D S Charney
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 8.  Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.

Authors:  J Biederman; T Spencer
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 9.  Norepinephrine involvement in antidepressant action.

Authors:  A Frazer
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

10.  Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity.

Authors:  M M Grant; J M Weiss
Journal:  Biol Psychiatry       Date:  2001-01-15       Impact factor: 13.382

View more
  46 in total

1.  Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.

Authors:  Heinrich J G Matthies; Jessica L Moore; Christine Saunders; Dawn Signor Matthies; Lynne A Lapierre; James R Goldenring; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.

Authors:  Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Toni S Shippenberg; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 3.  Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures.

Authors:  Katie J McLaughlin; Sarah E Baran; Cheryl D Conrad
Journal:  Mol Neurobiol       Date:  2009-07-31       Impact factor: 5.590

Review 4.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

5.  Ca2+ dependent surface trafficking of norepinephrine transporters depends on threonine 30 and Ca2+ calmodulin kinases.

Authors:  Uhna Sung; Francesca Binda; Valentina Savchenko; William A Owens; Lynette C Daws
Journal:  J Chem Neuroanat       Date:  2016-12-23       Impact factor: 3.052

6.  Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging.

Authors:  Benjamin Jacob Hayempour; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-11       Impact factor: 9.236

7.  Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.

Authors:  Susan L Erickson; Anjalika R Gandhi; Josephine K Asafu-Adjei; Allan R Sampson; LeeAnn Miner; Randy D Blakely; Susan R Sesack
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-06       Impact factor: 5.176

8.  Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.

Authors:  Robert H Pietrzak; Jean-Dominique Gallezot; Yu-Shin Ding; Shannan Henry; Marc N Potenza; Steven M Southwick; John H Krystal; Richard E Carson; Alexander Neumeister
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

Review 9.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

10.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.